Acasti Pharma Inc. | Ownership
Companies that own Acasti Pharma Inc.
Anson Funds Management LP
684,600
1.87%
684,600
0.89%
06/30/2018
Heights Capital Management, Inc.
559,835
1.53%
559,835
0.01%
12/31/2017
Perceptive Advisors LLC
206,677
0.56%
20,118
0%
06/30/2018
Arrow Capital Management, Inc.
194,193
0.53%
53,193
0.06%
06/30/2018
BMO Private Investment Counsel, Inc.
154,227
0.42%
0
0%
06/30/2018
Intact Investment Management, Inc.
48,990
0.13%
0
0%
06/30/2018
Virtu Financial BD LLC
41,066
0.11%
13,157
0%
06/30/2018
Morgan Stanley & Co. LLC
40,000
0.11%
0
0%
06/30/2018
Citadel Advisors LLC
32,648
0.09%
32,648
0%
06/30/2018
Renaissance Technologies LLC
18,600
0.05%
18,600
0%
06/30/2018
| Address |
545 Promenade du Centropolis
Laval Québec H7T 0A3
Canada
|
|
Employees
|
- |
| Website |
http://www.acastipharma.com |
| Updated |
07/08/2019 |
| Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. |
